Eli Lilly First to Launch Weight Loss Drug in Obesity-Hit India
Eli Lilly's Mounjaro medication.
Photographer: Montinique Monroe/BloombergThis article is for subscribers only.
Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.
Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a country that has the world’s third-largest number of obese people.